trastuzumab
CDR0000669882
Phase 3 mab active
Quick answer
trastuzumab for Breast Cancer is a Phase 3 program (mab) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Breast Cancer
- Phase
- Phase 3
- Modality
- mab
- Status
- active